Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Liver transplantation: an update for physicians.

L W Powell1

  • 1Department of Medicine University of Queensland, Royal Brisbane Hospital, Australia.

Australian and New Zealand Journal of Medicine
|August 1, 1989
PubMed
Summary

Liver transplantation offers a viable solution for end-stage liver disease, with Australian programs achieving comparable results to international centers. Advancements in techniques are increasing donor organ availability, making it a key therapeutic option.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Arthropathy in hereditary haemochromatosis segregates with elevated erythrocyte mean corpuscular volume.

Scandinavian journal of rheumatology·2020
Same author

Boron based separations for in situ recovery of L-erythrulose from transketolase-catalyzed condensation.

Biotechnology and bioengineering·2008
Same author

Patient-focused outcomes following detection in a hospital-based screening programme for C282Y haemochromatosis.

Internal medicine journal·2008
Same author

Use of community genetic screening to prevent HFE-associated hereditary haemochromatosis.

Lancet (London, England)·2005
Same author

HFE gene and hemochromatosis.

Journal of gastroenterology and hepatology·2004
Same author

A novel mutation in ferroportin1 is associated with haemochromatosis in a Solomon Islands patient.

Gut·2003

Area of Science:

  • Hepatology
  • Transplant Surgery
  • Medical Innovation

Background:

  • End-stage irreversible liver disease historically lacked effective treatments beyond symptomatic relief.
  • Previous management options for advanced liver disease were limited and often yielded suboptimal outcomes.

Purpose of the Study:

  • To evaluate the efficacy and resource implications of liver transplantation for end-stage liver disease.
  • To highlight the advancements and accessibility of liver transplantation in Australia.

Main Methods:

  • Analysis of outcomes from three established Australian liver transplant programs.
  • Review of new organ preservation techniques and reduced-size orthotopic transplantation in pediatric cases.

Main Results:

  • Australian liver transplant programs demonstrate results comparable to experienced international centers.
  • Successful liver transplantation can reverse end-stage liver disease with reasonable cost and resource utilization.
  • Innovations in organ preservation and pediatric transplantation are poised to increase donor organ availability.

Conclusions:

  • Liver transplantation is a feasible and effective therapeutic option for intractable, non-malignant chronic liver disease.
  • Consideration of orthotopic liver transplantation should be standard practice upon diagnosis of severe chronic liver disease.
  • Advancements in transplantation technology and Australian program success support broader adoption of this treatment.

Related Experiment Videos